EX-10 6 filename6.htmCollaborative Research, Development, Commercialization and License Agreement • May 5th, 2020 • Massachusetts
CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED.
EX-10.1 2 a13-13695_1ex10d1.htm EX-10.1 ***Text Omitted and Filed Separately with the Securities and Exchange Commission. Confidential Treatment Requested under 17 C.F.R. Sections 200.80(b)(4) and 240.24b-2. Execution Copy Confidential AMENDED AND...Collaborative Research, Development, Commercialization and License Agreement • May 5th, 2020
THIS AMENDED AND RESTATED AGREEMENT is entered into as of April 9, 2013 (“Amended and Restated Effective Date”) by and between SENOMYX, INC., a Delaware Corporation having offices at 4767 Nexus Centre Drive, San Diego, CA 92121, U.S.A. (“Senomyx”) and FIRMENICH SA, a Swiss Company, having its principal place of business at 1, route des Jeunes, 1211 Geneva 8, Switzerland (“Firmenich”).
AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • February 2nd, 2010 • Senomyx Inc • Services-commercial physical & biological research
THIS AGREEMENT is entered into as of the Effective Date by and between SENOMYX, INC., a Delaware Corporation having offices at 4767 Nexus Centre Drive, San Diego, CA 92121, U.S.A. (“Senomyx”) and FIRMENICH SA, a Swiss Company, having its principal place of business at 1, route des Jeunes, 1211 Geneva 8, Switzerland (“Firmenich”).
AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND PEPSICO, INC.Collaborative Research, Development, Commercialization and License Agreement • March 21st, 2017 • Senomyx Inc • Services-commercial physical & biological research • Delaware
This Amended and Restated Agreement (the “Agreement”) is entered into as of September 30, 2016 (the “Amended Effective Date”) by and between SENOMYX, INC., a Delaware Corporation having its principal place of business at 4767 Nexus Centre Drive, San Diego, CA 92121 (“SENOMYX”) and PEPSICO, INC., a North Carolina Corporation, having its principal place of business at 700 Anderson Hill Road, Purchase, NY 10577 (“PEPSICO”).
AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND FIRMENICH SACollaborative Research, Development, Commercialization and License Agreement • March 8th, 2018 • Senomyx Inc • Services-commercial physical & biological research
THIS AMENDED AND RESTATED AGREEMENT is entered into as of February 7, 2018, by and between SENOMYX, INC., a Delaware Corporation having offices at 4767 Nexus Centre Drive, San Diego, CA 92121, U.S.A. (“Senomyx”) and FIRMENICH SA, a Swiss Company, having its principal place of business at 1, route des Jeunes, 1211 Geneva 8, Switzerland (“Firmenich”).
FIRST AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • February 23rd, 2007 • Senomyx Inc • Services-commercial physical & biological research • California
This First Amendment is entered into as of October 6, 2006, by and between Senomyx, Inc. (“Senomyx”) and Ajinomoto Co., Inc. (“Ajinomoto”). Capitalized terms used herein without definition shall have the meaning provided therefor in the First Collaboration Agreement (as defined below).
FIRST AMENDMENT TO THE COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • February 4th, 2010 • Senomyx Inc • Services-commercial physical & biological research
THIS FIRST AMENDMENT TO THE COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT (the “First Amendment”) is made by and between SENOMYX, INC. (“Senomyx”), a Delaware corporation, having a principal place of business at 4767 Nexus Centre Drive, San Diego, CA 92121, and FIRMENICH SA, a Swiss Company, having its principal place of business at 1, route des Jeunes,1211 Geneva 8, Switzerland (“Firmenich”).
COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • August 9th, 2007 • Senomyx Inc • Services-commercial physical & biological research • Delaware
THIS AGREEMENT is entered into as of the Effective Date by and between SENOMYX, INC., a Delaware Corporation having offices at 4767 Nexus Centre Drive, San Diego, CA 92121, U.S.A. (“Senomyx”) and SOLAE, LLC, a Delaware Limited Liability Corporation, having its principal place of business at 1034 Danforth Drive, St. Louis, Missouri, USA 63102 (“Solae”).
SECOND AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • August 7th, 2008 • Senomyx Inc • Services-commercial physical & biological research • Delaware
This Second Amendment (“Second Amendment”) is entered into as of April 8, 2008 (“Second Amendment Effective Date”), by and between Senomyx, Inc. (“SENOMYX”) and The Coca-Cola Company (“KO”).
AMENDED AND RESTATED COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND FIRMENICH SACollaborative Research, Development, Commercialization and License Agreement • August 15th, 2018 • Senomyx Inc • Services-commercial physical & biological research • Delaware
THIS AMENDED AND RESTATED AGREEMENT is entered into as of February 7, 2018, by and between SENOMYX, INC., a Delaware Corporation having offices at 4767 Nexus Centre Drive, San Diego, CA 92121, U.S.A. (“Senomyx”) and FIRMENICH SA, a Swiss Company, having its principal place of business at 1, route des Jeunes, 1211 Geneva 8, Switzerland (“Firmenich”).
COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND THE COCA-COLA COMPANYCollaborative Research, Development, Commercialization and License Agreement • April 14th, 2004 • Senomyx Inc • Services-commercial physical & biological research • Delaware
This Agreement is entered into as of the April 22, 2002 (the "Effective Date") by and between SENOMYX, INC., a Delaware Corporation having its principal place of business at 11099 North Torrey Pines Road, La Jolla, CA 92037 ("SENOMYX") and THE COCA-COLA COMPANY, a Delaware Corporation, having its principal place of business at One Coca-Cola Plaza, Atlanta, Georgia 30313 ("KO").
DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND AJINOMOTO CO., INC.Collaborative Research, Development, Commercialization and License Agreement • May 5th, 2006 • Senomyx Inc • Services-commercial physical & biological research
THIS AGREEMENT is entered into as of March 23, 2006 (the “Effective Date”) by and between SENOMYX, INC., a Delaware Corporation having offices at 11099 North Torrey Pines Road, La Jolla, CA 92037, U.S.A. (“Senomyx”) and AJINOMOTO CO., INC., a Japanese Corporation, having its principal place of business at 15-1, Kyobashi 1-chome, Chuo-ku, Tokyo 104-8315, Japan (“Ajinomoto”).
FOURTH AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • May 7th, 2009 • Senomyx Inc • Services-commercial physical & biological research
This Fourth Amendment is entered into as of March 22, 2009 (“Fourth Amendment Effective Date”), by and between Senomyx, Inc. (“Senomyx”) and Ajinomoto Co., Inc. (“Ajinomoto”). Capitalized terms used herein without definition shall have the meaning provided therefor in the First Collaboration Agreement (as defined below).
COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND THE COCA-COLA COMPANYCollaborative Research, Development, Commercialization and License Agreement • June 9th, 2004 • Senomyx Inc • Services-commercial physical & biological research • Delaware
This Agreement is entered into as of the April 22, 2002 (the "Effective Date") by and between SENOMYX, INC., a Delaware Corporation having its principal place of business at 11099 North Torrey Pines Road, La Jolla, CA 92037 ("SENOMYX") and THE COCA-COLA COMPANY, a Delaware Corporation, having its principal place of business at One Coca-Cola Plaza, Atlanta, Georgia 30313 ("KO").
SECOND AMENDMENT TO THE COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • March 3rd, 2011 • Senomyx Inc • Services-commercial physical & biological research
THIS SECOND AMENDMENT TO THE COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT (the “Second Amendment”) is made by and between SENOMYX, INC. (“Senomyx”), a Delaware corporation, having a principal place of business at 4767 Nexus Centre Drive, San Diego, CA 92121, and FIRMENICH SA, a Swiss Company, having its principal place of business at 1, route des Jeunes, 1211 Geneva 8, Switzerland (“Firmenich”).
ANNEX 1 FIRST ADDENDUM TO COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • November 6th, 2008 • Senomyx Inc • Services-commercial physical & biological research
This First Addendum to the Collaborative Research, Development, Commercialization and License Agreement (this “Addendum”) is made and entered into as of September 1, 2008 by and between SOLAE, LLC (“Solae”), and SENOMYX, Inc. (“Senomyx”).
THIRD AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • November 2nd, 2007 • Senomyx Inc • Services-commercial physical & biological research
This Third Amendment is entered into as of August 1, 2007 (“Third Amendment Effective Date”), by and between Senomyx, Inc. (“Senomyx”) and Ajinomoto Co., Inc. (“Ajinomoto”). Capitalized terms used herein without definition shall have the meaning provided therefor in the First Collaboration Agreement (as defined below).
FIRST AMENDMENT TO THE COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • November 8th, 2012 • Senomyx Inc • Services-commercial physical & biological research • Delaware
This First Amendment to the Collaborative Research, Development, Commercialization and License Agreement (the “First Amendment”) is made as of August 2, 2012 (the “First Amendment Effective Date”) by and between SENOMYX, INC. (“SENOMYX”), a Delaware corporation, having a principal place of business at 4767 Nexus Centre Drive, San Diego, CA 92121, and PEPSICO, INC., a North Carolina Corporation, having its principal place of business at 700 Anderson Hill Road, Purchase, NY 10577 (“PEPSICO”).
SECOND AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENTCollaborative Research, Development, Commercialization and License Agreement • August 9th, 2007 • Senomyx Inc • Services-commercial physical & biological research
This Second Amendment is entered into as of April 24, 2007 (“Second Amendment Effective Date”), by and between Senomyx, Inc. (“Senomyx”) and Ajinomoto Co., Inc. (“Ajinomoto”). Capitalized terms used herein without definition shall have the meaning provided therefor in the First Collaboration Agreement (as defined below).
COLLABORATIVE RESEARCH, DEVELOPMENT, COMMERCIALIZATION AND LICENSE AGREEMENT BETWEEN SENOMYX, INC. AND PEPSICO, INC.Collaborative Research, Development, Commercialization and License Agreement • November 4th, 2010 • Senomyx Inc • Services-commercial physical & biological research • Delaware
This Agreement is entered into as of August 16, 2010 (the “Effective Date”) by and between SENOMYX, INC., a Delaware Corporation having its principal place of business at 4767 Nexus Centre Drive, San Diego, CA 92121 (“SENOMYX”) and PEPSICO, INC., a North Carolina Corporation, having its principal place of business at 700 Anderson Hill Road, Purchase, NY 10577 (“PEPSICO”).
